-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904.O3.6 904. Outcomes Research—Non-Malignant Conditions: Bleeding, Immune Thrombocytopenia, and Other Hematologic Disorders

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Bleeding Disorders, Hemophilia, Adult, antibodies, autoimmune disorders, Biological, Diseases, Bleeding and Clotting, Non-Biological, Elderly, platelets, Therapies, ITP, Pediatric, Biological Processes, MPN, Immune Disorders, Young Adult, Cell Lineage, Study Population, Clinically relevant, Myeloid Malignancies, Quality Improvement , immune mechanism, VWD
Saturday, December 5, 2020: 9:30 AM-11:00 AM
Susan E Creary, MD, Nationwide Children's Hospital and Rachael F. Grace, MD, Children's Hospital Boston
Grace: Agios: Research Funding; Dova: Membership on an entity's Board of Directors or advisory committees; Novartis: Research Funding; Pfizer: Research Funding.
9:30 AM

Kate Khair, PhD1,2*, Francis Nissen3*, Mariabeth Silkey3*, Tom Burke2*, Aijing Shang, MD, PhD3*, Martynas Aizenas3*, Oliver Meier3*, Jamie O'Hara, MSc2,4* and Declan Noone, MSc2*

1Haemnet, London, United Kingdom
2HCD Economics, Daresbury, United Kingdom
3F. Hoffmann-La Roche Ltd, Basel, Switzerland
4University of Chester, Chester, United Kingdom

9:45 AM

Meghan Pike, MD1, Ashley Chopek, MD2*, Nancy Young3*, Koyo Usuba3*, Mark J. Belletrutti, MD, MSc4, Robyn McLaughlin5*, Nancy Van Eyk5*, Amanda Bouchard5*, Kristen Matteson6* and Victoria E. Price, MBChB, MD5*

1IWK Health Centre, Bedford, NS, Canada
2CancerCare Manitoba, Winnipeg, MB, CAN
3Hospital for Sick Kids, Toronto, Canada
4Pediatrics, University of Alberta, Edmonton, AB, Canada
5IWK Health Centre, Halifax, NS, Canada
6Warren Alpert Medical School of Brown University, Providence

10:00 AM

Hanny Al-Samkari, MD1,2, Alexandria Cronin, MLIS3*, Donald M. Arnold, MD, MSc4, Francesco Rodeghiero, MD5 and Rachael F. Grace, MD1,6,7

1Harvard Medical School, Boston, MA
2Division of Hematology, Massachusetts General Hospital, Boston, MA
3Boston Children's Hospital, Boston, MA
4Michael G. DeGroote School of Medicine, Department of Medicine, McMaster University, Hamilton, ON, Canada
5Department of Haematology, Hematology Project Foundation, S. Bortolo Hospital, Vicenza, Vicenza, Italy
6Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Children's Hospital Boston, Boston, MA
7Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, Boston, MA

10:15 AM

Manpreet K Kochhar, MD1, Stephanie Grilo, PhD2*, Laura Robbins, DSW3*, Marina Catallozzi, MD2* and Cindy Neunert, MD2

1The Warren Alpert Medical School of Brown University, Providence, RI
2Columbia University, New York, NY
3Hospital for Special Surgery, New York, NY

10:30 AM

Amanda Wilson1*, Florence Joly2*, Gandarvaka Miles3*, Kammy Kuang3* and Huy P Pham, MD, MPH4*

1Sanofi, Cambridge, MA
2Sanofi, Chilly-Mazarin, France
3Aetion, Inc., New York, NY
4Department of Pathology, University of Southern California, Los Angeles, CA

10:45 AM

Rami S. Komrokji, MD1, Brady L. Stein, MD, MHSc2*, Robyn M. Scherber, MD3, Patricia Kalafut, PhD3*, Haobo Ren, PhD3* and Srdan Verstovsek, MD, PhD4

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL
3Incyte Corporation, Wilmington, DE
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH